AnGes, Inc. (TYO:4563)
57.00
-1.00 (-1.72%)
Apr 17, 2026, 3:30 PM JST
AnGes Employees
AnGes had 56 employees as of December 31, 2025. The number of employees increased by 1 or 1.82% compared to the previous year.
Employees
56
Change (1Y)
1
Growth (1Y)
1.82%
Revenue / Employee
15.61M JPY
Profits / Employee
-91.48M JPY
Market Cap
22.55B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 56 | 1 | 1.82% |
| Dec 31, 2024 | 55 | -90 | -62.07% |
| Dec 31, 2023 | 145 | 7 | 5.07% |
| Dec 31, 2022 | 138 | 7 | 5.34% |
| Dec 31, 2021 | 131 | 41 | 45.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Japan Tissue Engineering | 204 |
| ReproCELL | 99 |
| RaQualia Pharma | 85 |
| Immuno-Biological Laboratories | 58 |
| StemRIM | 45 |
| Stella Pharma | 43 |
| Kidswell Bio | 37 |
| Nano Holdings | 20 |